chartexchange

TG Therapeutics Reports Q3 2026 Earnings: EPS of $0.35 and Revenue of $259.9 Million Miss Estimates

GuruFocus | Nov 9, 2026 7:30 AM EST

BRIUMVI U.S. Net Product Revenue Jumps 52% Year-Over-Year as Company Repurchases $100 Million in Shares Related Stocks: TGTX ,

Read original article